SEC Form 4 · accession 0000904314-18-000002
ALLIED HEALTHCARE PRODUCTS INC · AHPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Weil
Director · 10% Owner
Period of report
Oct 4, 2018
Accepted (ET)
Oct 10, 2018 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874710
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F4 | Oct 4, 2018 | J | 59,272 | $0.00 | D | 60,520 | I | Trust |
| Common Stock | holding | — | — | — | 90,513 | D | ||
| Common Stock | holding | — | — | — | 2,500 | I | IRA | |
| Common StockF5 | holding | — | — | — | 94,427 | I | Spouse | |
| Common StockF6 | holding | — | — | — | 59,101 | I | Trust | |
| Common StockF7 | holding | — | — | — | 7,927 | I | Corporation | |
| Common StockF8 | holding | — | — | — | 137,736 | I | Limited Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2,F1 | $8.10 | holding | — | — | — | Nov 13, 2009 | Nov 13, 2018 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $10.08 | holding | — | — | — | Nov 13, 2010 | Nov 13, 2019 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $8.68 | holding | — | — | — | Nov 11, 2011 | Nov 11, 2020 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $7.10 | holding | — | — | — | Nov 10, 2012 | Nov 10, 2021 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $5.18 | holding | — | — | — | Nov 8, 2013 | Nov 8, 2022 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $4.62 | holding | — | — | — | Nov 14, 2014 | Nov 14, 2023 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $3.16 | holding | — | — | — | Nov 13, 2015 | Nov 13, 2024 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $2.34 | holding | — | — | — | Nov 12, 2016 | Nov 12, 2025 | Common Stock | 750 | 750 | D |
| Option (right to buy)F2,F1 | $2.26 | holding | — | — | — | Nov 10, 2017 | Nov 10, 2026 | Common Stock | 750 | 750 | D |
| Option (right to buy) | $2.22 | holding | — | — | — | Nov 9, 2018 | Nov 9, 2027 | Common Stock | 750 | 750 | D |
Explanation of responses
- F1Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
- F2Information being corrected due to reverse stock split effected December 5, 2016.
- F3Shares disposed of in a transfer for no consideration from a trust to the beneficiaries of the trust.
- F4Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
- F5The reporting person disclaims any economic benefit in such shares.
- F6Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
- F7Owned by a corporation controlled by the reporting person.
- F8Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).